Research indicates that the acetylated and amidated variants of BPC-157 demonstrate markedly higher strength and resistance to enzymatic breakdown within the gastrointestinal tract, thus supporting their bioavailability in research contexts
The aesthetics of the product are nice, she said
Studies indicate that around 90% of patients with hEDS experience gastrointestinal challenges that can include reflux, slow gastric emptying, low motility, dysphagia (trouble swallowing), gastroparesis, constipation, IBS and functional dyspepsia, which is characterised as pain or discomfort in the upper abdomen, bloating, belching, nausea, and an unusual feeling of fullness after meals (4,6,7,11)
That makes it less irritating than other glycolic acid formulas
Contact your GP if you experience: No improvement after 46 weeks of treatment : Whilst neurological symptoms may take longer to resolve, you should notice some improvement in energy levels or general wellbeing within this timeframe